A Study of a Single Subcutaneous Dose of ALXN1210 in Healthy Adult Participants
Clinical trial NCT05288829 · COMPLETED
Trial details
- NCT number
- NCT05288829
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-19
- Primary completion
- 2017-07-18
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.